Larvol Delta - Elevation-Oncology-Presents-Preclinical-ProofofConcept-Data-Supporting-Combination-Potential-of-EO3021-with-VEGFR2-or-PD1-Inhibitors-at-ESMO-ImmunoOncology-Annual-Congress-2024

EO-3021 - Elevation Oncology

https://www.prnewswire.com/news-releases/elevation-oncology-presents-preclinical-proof-of-concept-data-supporting-combination-potential-of-eo-3021-with-vegfr2-or-pd-1-inhibitors-at-esmo-immuno-oncology-annual-congress-2024-302323503.html

Dec 5, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next